GLP-3 RT (Retatrutide)
Retatrutide is an investigational triple-receptor agonist that targets the GLP-1, GIP, and glucagon pathways. It is currently being studied for its potential role in metabolic health and weight management.
Research use only; not FDA-approved for human use
GLP-3 RT (Retatrutide)
Retatrutide is an investigational triple-receptor agonist that targets the GLP-1, GIP, and glucagon pathways. It is currently being studied for its potential role in metabolic health and weight management.
Research use only; not FDA-approved for human use